These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 13678555)

  • 21. Imaging opiate receptors in the human brain with positron emission tomography. Potential applications for drug addiction research.
    Sadzot B; Mayberg HS; Frost JJ
    Acta Psychiatr Belg; 1990; 90(1):9-19. PubMed ID: 1670391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From rats to humans and return: testing addiction hypotheses by combined PET imaging and self-reported measures of psychostimulant effects. Commentary on Volkow et al. 'Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies'.
    Di Chiara G
    Behav Pharmacol; 2002 Sep; 13(5-6):371-7. PubMed ID: 12394413
    [No Abstract]   [Full Text] [Related]  

  • 23. Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO.
    Boileau I; Nakajima S; Payer D
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1410-20. PubMed ID: 26141509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translating positron emission tomography studies in animals to stimulant addiction: promises and pitfalls.
    Caprioli D; Fryer TD; Sawiak SJ; Aigbirhio FI; Dalley JW
    Curr Opin Neurobiol; 2013 Aug; 23(4):597-606. PubMed ID: 23664005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychiatric disorders: investigation of schizophrenia and substance abuse.
    Volkow ND; Fowler JS
    Semin Nucl Med; 1992 Oct; 22(4):254-67. PubMed ID: 1439871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain imaging studies of cocaine abuse: implications for medication development.
    London ED; Bonson KR; Ernst M; Grant S
    Crit Rev Neurobiol; 1999; 13(3):227-42. PubMed ID: 10803636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation.
    Gould RW; Porrino LJ; Nader MA
    Curr Top Behav Neurosci; 2012; 11():25-44. PubMed ID: 22020537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging the neurochemistry of alcohol and substance abuse.
    Martinez D; Kim JH; Krystal J; Abi-Dargham A
    Neuroimaging Clin N Am; 2007 Nov; 17(4):539-55, x. PubMed ID: 17983969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the treatment of drug abuse with molecular imaging.
    Schiffer WK; Liebling CN; Patel V; Dewey SL
    Nucl Med Biol; 2007 Oct; 34(7):833-47. PubMed ID: 17921034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review.
    Wang GJ; Volkow ND; Thanos PK; Fowler JS
    J Addict Dis; 2004; 23(3):39-53. PubMed ID: 15256343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural and functional brain recovery in individuals with substance use disorders during abstinence: A review of longitudinal neuroimaging studies.
    Parvaz MA; Rabin RA; Adams F; Goldstein RZ
    Drug Alcohol Depend; 2022 Mar; 232():109319. PubMed ID: 35077955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human brain imaging and substance abuse.
    Lingford-Hughes A
    Curr Opin Pharmacol; 2005 Feb; 5(1):42-6. PubMed ID: 15661624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroimaging for drug addiction and related behaviors.
    Parvaz MA; Alia-Klein N; Woicik PA; Volkow ND; Goldstein RZ
    Rev Neurosci; 2011; 22(6):609-24. PubMed ID: 22117165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission tomography in studies of drug abuse.
    London ED
    NIDA Res Monogr; 1994; 138():15-24. PubMed ID: 7603540
    [No Abstract]   [Full Text] [Related]  

  • 35. Brain imaging in nonhuman primates: insights into drug addiction.
    Nader MA; Czoty PW
    ILAR J; 2008; 49(1):89-102. PubMed ID: 18172336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights from recent positron emission tomographic studies of drug abuse and dependence.
    Chang L; Haning W
    Curr Opin Psychiatry; 2006 May; 19(3):246-52. PubMed ID: 16612209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addiction and imaging of the living human brain.
    Gatley SJ; Volkow ND
    Drug Alcohol Depend; 1998; 51(1-2):97-108. PubMed ID: 9716933
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term effects of "ecstasy" use on serotonin transporters of the brain investigated by PET.
    Buchert R; Thomasius R; Nebeling B; Petersen K; Obrocki J; Jenicke L; Wilke F; Wartberg L; Zapletalova P; Clausen M
    J Nucl Med; 2003 Mar; 44(3):375-84. PubMed ID: 12621003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positron emission tomography studies in parkinsonism.
    Eidelberg D
    Neurol Clin; 1992 May; 10(2):421-33. PubMed ID: 1584183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of Nonhuman Primates in Substance Use Disorders Research.
    Banks ML; Czoty PW; Negus SS
    ILAR J; 2017 Dec; 58(2):202-215. PubMed ID: 28531265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.